MedTrace Logo

Metabolic Response to Chardonnay Grape Marc Powder

NCT03203915 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2021-07-16

No results posted yet for this study

Summary

To determine if the addition of chardonnay grape marc (also called pomace) powder enriched with grape seed extract to the diet will result in reducing blood levels of cholesterol or triglycerides.

Conditions

Interventions

DIETARY_SUPPLEMENT

Chardonnay grape marc marc high polyphenol dose (120mg)

3 prepackaged capsules taken once in the morning with meal for 3 weeks. The total dose will be 120mg of total polyphenols

DIETARY_SUPPLEMENT

Chardonnay grape marc powder low polyphenol dose (75mg)

3 prepackaged capsules taken once in the morning with meal for 3 weeks. The total dose will be 75mg of total polyphenols

DIETARY_SUPPLEMENT

Placebo (0mg)

3 prepackaged capsules taken once in the morning with meal for 3 weeks. The total dose will be 0mg of polyphenols

Sponsors & Collaborators

  • Sonomaceuticals LLC

    collaborator UNKNOWN

  • USDA, Western Human Nutrition Research Center

    lead FED

Principal Investigators

  • Nancy L Keim, PhD · United States Department of Agriculture (USDA)

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2019-06-28
Completion
2019-06-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03203915 on ClinicalTrials.gov